Episode Details
Back to Episodes
Author Interview: Doctor Mark Gibson, October 2026
Published 12 hours ago
Description
Join Professor Peter Nash from Griffith University in Brisbane and Doctor Mark Gibson from the Centre for Rheumatic Diseases, King’s College London, as they discuss Doctor Gibson’s recent paper, ‘Cancer risk of Janus kinase inhibitors and other advanced therapies in immune-mediated inflammatory diseases: a systematic review and Bayesian network meta-analysis of RCTs’.